CoV-2 N (329 a.a.)

Coronavirus 2019 Nucleocapsid (329 a.a.), Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Role of Residue 329 and Adjacent Regions

Residue 329 lies within the CTD’s RNA-binding interface, which interacts with the SARS-CoV-2 stem-loop 2 motif (s2m), a conserved RNA element critical for viral packaging. Key findings include:

RNA Binding Mechanism

  • Cross-linking studies (CLIR-MS) identified Thr329 and Trp330 as direct contact points with s2m RNA, particularly near the GUAC tetranucleotide at the 3’ asymmetric loop .

  • Electrostatic interactions: The CTD dimer’s positively charged surface facilitates RNA binding, with Trp330 forming π-stacking interactions with RNA bases .

Mutational Analysis

ResidueMutationFunctional ImpactSource
Thr329T329AReduces RNA affinity by ~40%
Trp330W330AAbolishes RNA binding
Leu331L331ADisrupts dimer stability

Evolutionary Conservation and Variability

  • Conservation: Residues 329–331 are highly conserved across SARS-CoV-2 variants, with no reported mutations in over 38,000 sequenced genomes .

  • Adjacent mutations: The CTD harbors 315 amino acid substitutions in global sequences, but none directly impact the dimer interface or RNA-binding residues .

Implications for Therapeutics

  • Antibody targeting: The N protein’s CTD is immunodominant, with monoclonal antibodies (e.g., nCoV396) showing cross-reactivity against SARS-CoV and MERS-CoV CTDs .

  • Small-molecule inhibition: Compounds like PJ34 disrupt CTD dimerization, reducing viral replication by 90% in vitro .

Key Research Findings

  1. RNA binding plasticity: Phosphorylation of the LKR modulates CTD accessibility, enabling dynamic RNA interactions during viral assembly .

  2. Immune evasion: The CTD suppresses type-I interferon (IFN) signaling, with residues 329–331 implicated in shielding viral RNA from host sensors .

  3. Structural flexibility: Molecular dynamics simulations reveal that Trp330 stabilizes RNA through conformational adjustments, enabling adaptation to host cell environments .

Outstanding Questions

  • How do post-translational modifications (e.g., phosphorylation) regulate residue 329’s role in RNA binding?

  • Can CTD-targeted therapies overcome viral mutational escape?

Product Specs

Introduction

Initially identified in Wuhan, China, in December 2019, the 2019 novel coronavirus (2019-nCoV) is a human coronavirus responsible for causing viral pneumonia.

Genetic analysis reveals that 2019-nCoV shares 87% of its identity with the bat-derived severe acute respiratory syndrome coronavirus 2018 (SARS-CoV-2), originally found in Zhoushan, eastern China. Although structurally similar to the 2018 SARS-CoV receptor-binding domain (RBD), slight variations suggest that 2019-nCoV might bind to the human angiotensin-converting enzyme 2 (ACE2) receptor protein.

Bats are considered the likely natural reservoir of 2019-nCoV; however, researchers hypothesize that an intermediary animal host, potentially from the seafood market, played a role in transmission to humans. Genomic analysis indicates that 2019-nCoV might be a recombinant virus, with its spike glycoprotein originating from a combination of bat coronavirus and another unidentified coronavirus.

Description

This recombinant protein is derived from E. coli and encompasses the C-terminal region (329 amino acids) of the Coronavirus 2019 Nucleocapsid protein. It is fused with a GST-6xHis tag at the N-terminal and exhibits a molecular weight of 63.5 kDa.

Physical Appearance

The product appears as a clear solution that has undergone sterile filtration.

Formulation

The CoV-2 Nucleocapsid protein solution is provided in a buffer containing 50mM Tris-HCl at pH 8, 1M Urea, and 50% Glycerol.

Stability

The CoV-2 Spike Protein is shipped in a cold chain using ice packs. Upon receipt, it should be stored at -20 degrees Celsius.

Purity

The purity of the CoV-2 Nucleocapsid protein exceeds 95%, as determined by SDS-PAGE analysis.

Source

E.Coli.

Purification Method

NTA Sepharose-Affinity Purification.

Q&A

What is the structural composition of the SARS-CoV-2 N protein?

The SARS-CoV-2 N protein is encoded by the ninth ORF of the virus and comprises 419 amino acids. Its modular organization includes both intrinsically disordered regions (IDRs) and conserved structural regions. The IDRs consist of three modules: N-arm, central Ser/Arg-rich flexible linker region (LKR), and C-tail. The conserved structural regions include two domains: N-terminal domain (NTD) and C-terminal domain (CTD). In the primary structure, NTD and CTD are connected by LKR and flanked by N-arm and C-tail .

What are the primary RNA-binding sites in the N protein?

The N protein contains multiple RNA-binding sites distributed across its domains. Within the N-NTD, a protruding β-hairpin (β2′–β3′) composed mostly of basic amino acid residues forms a positively charged pocket at the junction with the core structure, serving as a putative RNA binding site. Specific arginine residues (R92, R107, and R149) directly interact with RNA. The N-CTD dimer contains another RNA binding domain with a positively charged groove in its helical face, consisting of residues K256, K257, K261, and R262. Additionally, both the N-terminal IDR and the LKR exhibit RNA binding activity, enhancing binding affinity and enabling the N protein to bind RNA with high cooperativity .

How can researchers distinguish between N protein conformational states?

Researchers can employ single-molecule spectroscopy combined with all-atom simulations to uncover the molecular details that contribute to N protein conformational states. The N protein contains three dynamic disordered regions that house putatively transiently-helical binding motifs. Flow cytometry analysis can be performed using specific gating strategies: isolating live cells with LIVE/DEAD dye vs. FSC-A, identifying singlet cells via FSC-A vs. FSC-H and SSC-A vs. SSC-W, and characterizing CD3+ cells and subsequently CD8+ or CD4+ populations. Different protein states can be monitored through their distinct interactions with other viral components and cellular machinery .

How can protein-protein interactions between N protein and other viral components be studied experimentally?

Protein pull-down assays provide an effective method for studying N protein interactions. This approach involves using purified recombinant proteins (such as ACE2 with different tags) as bait and cell-associated viral proteins as targets. Specifically, protein-bound beads are incubated with solubilized viral components, washed to remove non-specific interactions, and then bound proteins are eluted using appropriate buffers (such as imidazole for His-tagged proteins or citric acid for Fc-tagged proteins). The samples can then be analyzed by SDS-PAGE and western blotting with specific antibodies. This methodology allows researchers to systematically investigate how mutations in the N protein affect its interactions with other viral components .

What experimental systems can model N protein dynamics in viral assembly?

Virus-like particle (VLP) systems offer a valuable platform for investigating N protein dynamics during viral assembly. By co-transfecting cells with plasmids encoding viral structural proteins, researchers can generate particles that mimic authentic virion assembly without requiring infectious virus. This system has revealed that the C-terminal domain (CTD) of the N protein is essential for interaction with the membrane (M) protein during budding. Interestingly, while the isolated CTD lacks M protein interaction capacity and budding ability, fusion with the N-terminal domain (NTD) or the linker region (LKR) enables RNA-dependent interactions with the M protein and confers budding capabilities. These findings demonstrate how VLP systems can elucidate domain-specific functions within the N protein during assembly processes .

What techniques can measure N protein-mediated phase separation?

N protein undergoes liquid-liquid phase separation when mixed with RNA, a property that can be quantified using various biophysical techniques. Single-molecule spectroscopy combined with turbidity measurements can detect the formation of condensates. Fluorescence microscopy with labeled N protein and RNA can visualize phase separation in real-time. Polymer theory can be applied to predict how the multivalent interactions that drive phase separation also promote RNA compaction. These techniques have led to a symmetry-breaking model wherein single-genome condensation preferentially occurs over bulk phase separation, suggesting that phase separation serves as a macroscopic indicator of key nanoscopic interactions crucial for viral genome packaging .

How do mutations in the N protein affect viral fitness and assembly?

Mutations in the N protein can significantly impact viral fitness by altering assembly efficiency. Competitive assays indicate that variants carrying mutations such as R203K/G204R exhibit enhanced replication compared to original variants, likely due to improved ribonucleoprotein (RNP) assembly. These mutations increase binding affinity to viral RNA, thereby optimizing genome packaging. The emergence of the N* variant (NΔN209) in the SARS-CoV-2 B.1.1 lineage suggests that portions of the N-terminal domain may be dispensable for virus particle assembly, potentially providing adaptive advantages. This evolutionary trend indicates that SARS-CoV-2 may be optimizing the N protein structure for more efficient assembly processes, a pattern also observed in other β-coronaviruses like SARS-CoV and HCoV-OC43 .

What is the role of the C-tail in N protein function?

The C-tail, one of the intrinsically disordered regions of the N protein, plays a vital role in genome encapsidation. Research using virus-like particles has demonstrated that the presence of the C-tail is essential for efficient genomic RNA packaging by the N protein, a process potentially regulated through interactions with the M protein. While the CTD is critical for M protein interaction during budding, it requires connection to other domains to function properly. This finding highlights how the modular organization of the N protein, with both structured domains and disordered regions, creates a functional hierarchy where the C-tail serves as an important regulatory element in the assembly process .

How does the N protein selectively package viral genomic RNA?

The selective packaging of viral genomic RNA by the N protein involves a complex mechanism combining structural recognition and phase separation principles. The N protein contains multiple RNA binding domains with varying affinities and specificities for different RNA structures. During infection, the N protein and viral genomic RNA (gRNA) undergo phase separation in the cytosol, forming condensates where a discrete pre-capsid state develops. Within these condensates, gRNA association with helical nucleocapsid structures occurs. This process facilitates selective packaging through dynamic multivalent interactions between N proteins and gRNA, creating heterogeneous and dynamic interactions that drive genome compaction. Upon maturation, the pre-capsid is released from the condensate and proceeds to virion assembly by interacting with membrane-bound structural proteins (M, E, and S) at the ER-to-Golgi intermediate compartment .

How can N protein research inform vaccine development strategies?

N protein research provides valuable insights for vaccine development strategies beyond the commonly targeted spike protein. The N protein induces strong CD8+ T cell immune responses, which are crucial for long-term protection against viral infection. Engineered extracellular vesicles (EVs) containing the N protein have been shown to generate potent SARS-CoV-2 N-specific CD8+ T immunity. Flow cytometry analysis demonstrates that these responses can be carefully characterized using specific gating strategies to identify CD8+ T cell populations with activation markers such as CD44. The high conservation of the N protein across coronavirus variants (approximately 90% homology between SARS-CoV-2 and SARS-CoV) suggests that N-protein-based vaccines might provide broader protection against emerging variants and related coronaviruses .

What N protein domains represent promising antiviral targets?

Several domains within the N protein present promising targets for antiviral development. The RNA-binding regions in both the NTD and CTD contain well-defined pockets that could be targeted by small molecule inhibitors to disrupt viral genome packaging. The NTD contains a positively charged pocket formed by the β2′–β3′ β-hairpin junction with the core structure, while the CTD features a positively charged groove composed of K256, K257, K261, and R262 residues. Additionally, interfaces involved in N protein dimerization and phase separation represent potential intervention points. The C-terminal domain's interaction with the M protein during viral assembly offers another promising target, as disrupting this interaction could prevent efficient virion formation without affecting host cellular processes .

How does the phase separation property of N protein relate to potential therapeutic strategies?

The phase separation property of the N protein presents novel therapeutic opportunities. Compounds that disrupt the multivalent interactions driving phase separation could prevent efficient viral genome packaging and assembly. Since phase separation appears to be a prerequisite for genome condensation and pre-capsid formation, targeting this property could inhibit a critical step in viral replication. Polymer theory suggests that the same interactions driving phase separation also facilitate RNA compaction, indicating that disrupting these interactions could simultaneously affect multiple aspects of viral assembly. Therapeutic strategies might involve small molecules that bind to the intrinsically disordered regions or structured domains of the N protein that mediate phase separation, thereby preventing the formation of functional viral ribonucleoprotein complexes .

What is the relationship between N protein flexibility and function?

The N protein's functional versatility stems from its unique structural organization combining ordered domains with intrinsically disordered regions. Single-molecule spectroscopy combined with all-atom simulations has revealed that the two folded domains (NTD and CTD) interact minimally, rendering the full-length N protein a flexible and multivalent RNA-binding protein. This flexibility enables the N protein to adapt to various binding partners and conformational states required during different stages of the viral life cycle. The disordered regions house transiently-helical binding motifs that can undergo disorder-to-order transitions upon interaction with binding partners, providing a mechanism for regulated binding. This structural plasticity facilitates the N protein's multiple roles in viral genome packaging, replication, and assembly .

How do N-M protein interactions facilitate viral assembly?

Domain CombinationM Protein InteractionBudding CapabilityRNA Dependence
Isolated CTDNoNoN/A
NTD/CTDYesYesRNA-dependent
LKR/CTDYesYesRNA-dependent
Full-length NYesYesRNA-dependent

What is the significance of N protein evolutionary conservation across coronaviruses?

The high evolutionary conservation of the N protein across coronaviruses (approximately 90% homology between SARS-CoV-2 and SARS-CoV N proteins) underscores its functional importance. This conservation extends to the modular organization with intrinsically disordered regions and structured domains. The emergence of the N* variant (NΔN209) in the SARS-CoV-2 B.1.1 lineage, along with comparable observations in SARS-CoV and HCoV-OC43, suggests a common evolutionary path toward optimizing the N protein for assembly efficiency. The CTD-based assembly mechanism appears to be conserved among β-coronaviruses, representing a fundamental process that has been maintained throughout coronavirus evolution. This conservation highlights the N protein as a potential target for broad-spectrum antiviral strategies that could be effective against multiple coronaviruses .

What are the current limitations in N protein structural analysis?

Despite significant progress, several challenges remain in comprehensive structural analysis of the SARS-CoV-2 N protein. The intrinsically disordered regions, comprising approximately 40% of the protein, resist traditional structural determination methods like X-ray crystallography. While domains such as the NTD and CTD have been characterized, the conformational ensemble of the full-length protein and how these domains interact dynamically during function remains incompletely understood. Additionally, structural changes induced by RNA binding, protein-protein interactions, and phase separation are difficult to capture using static structural methods. Advanced approaches combining single-molecule techniques, cryo-electron microscopy, and molecular dynamics simulations are needed to fully elucidate the structural basis of N protein function in different contexts and conformational states .

How can research on N protein phase separation be advanced?

Future research on N protein phase separation should focus on understanding the molecular determinants and physiological regulators of this process. More detailed investigations are needed to determine how specific sequence elements within the N protein contribute to phase separation and how this property is regulated during infection. Advanced microscopy techniques combined with in vitro reconstitution systems could help visualize the dynamics of phase separation in real-time. Developing quantitative models that link phase separation to functional outcomes like genome packaging would provide valuable insights. Additionally, exploring how host factors and viral components modulate N protein phase separation could reveal new regulatory mechanisms and potential therapeutic targets. Comparative studies across different coronavirus N proteins might identify conserved principles governing phase separation in viral assembly .

What new methodologies might advance our understanding of N protein function in viral replication?

Emerging methodologies hold promise for advancing our understanding of N protein function. Single-cell techniques combining transcriptomics and proteomics could reveal how N protein activity varies across infected cells and infection stages. Advanced imaging approaches like super-resolution microscopy and live-cell tracking can visualize N protein dynamics during infection. CRISPR-based screening methods might identify host factors that interact with the N protein and influence its function. Synthetic biology approaches, creating minimal systems that recapitulate N protein functions, could define the essential components and interactions required for viral replication and assembly. Development of biosensors that report on N protein conformational states or binding events in living cells would provide valuable real-time information about its function during infection .

How do mutations in N protein contribute to SARS-CoV-2 variant fitness?

Mutations in the N protein contribute significantly to SARS-CoV-2 variant fitness through multiple mechanisms. The R203K/G204R mutations, which have increased in prevalence among variants of concern, enhance viral replication by improving ribonucleoprotein assembly efficiency and increasing binding affinity to viral RNA. The emergence of the N* variant (NΔN209) in the B.1.1 lineage suggests that portions of the N-terminal domain may be dispensable for viral assembly, potentially streamlining the assembly process. These adaptive mutations illustrate how the virus can enhance its replication by fine-tuning assembly mechanisms. Comparative analysis of these mutations across different variants provides insights into convergent evolution, where similar functional optimizations arise independently in different lineages .

Product Science Overview

Structure and Function

The N protein is composed of 329 amino acids and is highly conserved among coronaviruses. It is divided into two main domains:

  1. N-terminal domain (NTD): Involved in RNA binding.
  2. C-terminal domain (CTD): Facilitates protein-protein interactions.

These domains are connected by a linker region rich in serine and arginine residues, which is crucial for the protein’s function .

Role in Viral Life Cycle

The N protein is essential for several stages of the SARS-CoV-2 life cycle:

  • RNA Packaging: It binds to the viral RNA genome, forming a ribonucleoprotein complex that is essential for the packaging of the viral genome into new virions .
  • Viral Assembly: It interacts with other viral structural proteins, such as the membrane (M) and envelope (E) proteins, to facilitate the assembly of new virus particles .
  • Immune Response: The N protein is highly immunogenic and elicits a strong immune response, making it a potential target for vaccine and diagnostic development .
Recombinant Nucleocapsid Protein

Recombinant N proteins are produced using various expression systems, such as bacteria, yeast, or mammalian cells. These recombinant proteins are used in research and diagnostic applications, including:

  • Vaccine Development: As a target for vaccine candidates due to its immunogenic properties .
  • Diagnostic Tests: Utilized in serological assays to detect antibodies against SARS-CoV-2 in infected individuals .
Research and Applications

Recent studies have highlighted the importance of the N protein in understanding the pathogenesis of SARS-CoV-2 and developing therapeutic strategies . For instance, mutations in the N protein have been linked to changes in viral replication and pathogenicity . Additionally, structural insights obtained through techniques like cryo-electron microscopy have provided valuable information for drug design .

In conclusion, the Coronavirus 2019 Nucleocapsid (329 a.a.), Recombinant, is a vital component in the study of SARS-CoV-2, offering significant potential for vaccine and diagnostic development, as well as enhancing our understanding of the virus’s life cycle and pathogenicity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.